NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Basal Cell Carcinoma


Return to Library

Free Basal Cell Carcinoma Articles


Study findings from Stanford University broaden understanding of basal cell cancer



2009 JUL 13 - (NewsRx.com) -- According to recent research published in the Journal of the American Academy of Dermatology, "Large scalp defects can be challenging to repair because of the inelasticity of the scalp. While there are several methods to close this type of wound, they result in either alopecia or unacceptable scarring."

"We present a dual transposition flap to close a large defect following Mohs surgery for a basal cell carcinoma on the scalp. We describe and report the case of a man with a basal cell carcinoma on the scalp vertex who had been referred for Mohs micrographic surgery. The surgery resulted in a large scalp defect. A dual transposition flap performed with tumescent anesthesia was used in a delayed closure of a 78.5-cm(2) defect. It resulted in minimal alopecia, minimal distortion of the hair orientation, and minimal scar stretch-back. Limitations: The limitation of this study is that this technique is based on one case report. This dual transposition flap is a good reconstructive option for large, immobile scalp defects," wrote E.F. Fincher and colleagues, Stanford University.

The researchers concluded: "It can be performed under local anesthesia with minimal alopecia and camouflaged scars. (J Am Acad Dermatol 2009;60:985-9.)'."

Fincher and colleagues published their study in the Journal of the American Academy of Dermatology (Dual transposition flaps for the reconstruction of large scalp defects. Journal of the American Academy of Dermatology, 2009;60(6):985-989).

For additional information, contact H.B. Gladstone, Stanford University, School Medical, Division Dermatology Surgery, Dept. of Dermatology, 900 Blake Wilbur Dr., Stanford, CA 94305, USA.

The publisher's contact information for the Journal of the American Academy of Dermatology is: Mosby-Elsevier, 360 Park Avenue South, New York, NY 10010-1710, USA.

Keywords: United States, Stanford, Alopecia, Basal Cell Cancer, Basal Cell Carcinoma, Dermatology, Oncology, Surgery, Stanford University.

This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login